- Home
- MIRM vs M Comparison
MIRM vs M Comparison
Compare MIRM & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | M |
|---|---|---|
| Founded | 2018 | 1830 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.9B |
| IPO Year | 2019 | 2003 |
Fundamental Metrics
Financial Performance| Metric | MIRM | M |
|---|---|---|
| Price | $82.56 | $23.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | ★ $153.07 | $23.18 |
| AVG Volume (30 Days) | 766.8K | ★ 6.0M |
| Earning Date | 11-03-2026 | 12-02-2026 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | ★ 74.59 | 12.08 |
| EPS | N/A | ★ 0.85 |
| Revenue | $19,138,000.00 | ★ $22,621,000,000.00 |
| Revenue This Year | $33.62 | N/A |
| Revenue Next Year | $17.72 | N/A |
| P/E Ratio | ★ N/A | $28.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $63.23 | $16.69 |
| 52 Week High | $130.00 | $26.59 |
Technical Indicators
Market Signals| Indicator | MIRM | M |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 57.06 |
| Support Level | $77.78 | $21.81 |
| Resistance Level | $88.31 | $24.02 |
| Average True Range (ATR) | 3.86 | 0.83 |
| MACD | 0.31 | 0.15 |
| Stochastic Oscillator | 39.16 | 66.26 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.